🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with numerous of participants share comparison images, injection guides and assertions of rapid British shipping. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

However, physicians and chemists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.

Some experts stated the popularity for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, risking penalties, legal action or prison.

Platform Response and Content Removal

Based on TikTok, the service has removed violative content and banned associated keywords and search suggestions. The organization stated it was committed to keeping the service safe and investing in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also discovered communities with up to nine thousand participants marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with numerous of members, populated with images of slimming results, glowing reviews and step-by-step instructions for preparing or administering at home.

After minutes of joining one group, a seller shared contact information, where most purchases occur. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Item Information and Pricing

Inside these communities, posts display black plastic parcels with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram stated it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.

Her team has already encountered patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to potentially significant health risks”.